Page 9 - Sciences Ltd News Today

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 13,880,000 shares, a growth of 32.8% from the March 15th total of 10,450,000 shares. Based on an average trading volume of 2,730,000 shares, the days-to-cover ratio is […]

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) have been assigned a consensus recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in […]

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) have received a consensus rating of “Buy” from the six research firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have issued a report on the […]

China Universal Asset Management Co. Ltd. acquired a new position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 7,369 shares of the company’s stock, valued at approximately $59,000. A number of other hedge funds and other institutional investors have also recently added […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) shares traded down 3.9% during mid-day trading on Wednesday following insider selling activity. The stock traded as low as $7.30 and last traded at $7.34. 347,488 shares were traded during trading, a decline of 87% from the average session volume of 2,708,183 shares. The stock had previously closed […]

Should You Buy or Sell Roivant Sciences Stock? Get The Latest ROIV Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Global Viscosupplementation Market is expected to reach US$ 6.27 Billion by 2028 According to the research. Patients with osteoarthritis have a minimally...

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) hit a new 52-week high during mid-day trading on Friday after Citigroup raised their price target on the stock from $11.00 to $14.00. Citigroup currently has a buy rating on the stock. Roivant Sciences traded as high as $9.08 and last traded at $8.87, with a […]

The market for Pharmaceutical Vials is predicted to grow at a CAGR of 7% from its estimated value of US$ 11 billion in 2021.You can find a summary of current trends, market data, and sales projections for the years 2023–2032 in the study named Global Pharmaceutical Vials Market. This report uses data from the year 2...

/PRNewswire/ -- VectorBuilder is the worlds largest supplier of customized vectors for viral and non-viral gene delivery, operating as a multinational...